Concomitant Use of Sulforaphane Enhances Antitumor Efficacy of Sunitinib in Renal Cell Carcinoma In Vitro

SIMPLE SUMMARY: Despite recent advances in treating metastatic renal cell carcinoma (RCC), many patients develop resistance to therapy, resulting in treatment failure. Sunitinib is one drug used to treat metastasized RCC and resistance eventually develops in most patients. In the present in vitro in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsaur, Igor, Thomas, Anita, Taskiran, Emine, Rutz, Jochen, Chun, Felix K.-H., Haferkamp, Axel, Juengel, Eva, Blaheta, Roman A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562895/
https://www.ncbi.nlm.nih.gov/pubmed/36230567
http://dx.doi.org/10.3390/cancers14194643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562895/
https://www.ncbi.nlm.nih.gov/pubmed/36230567
http://dx.doi.org/10.3390/cancers14194643

Ejemplares similares